Differentiation of the drug‐binding sites of calmodulin
- 1 April 1987
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 164 (2) , 411-420
- https://doi.org/10.1111/j.1432-1033.1987.tb11073.x
Abstract
Calmodulin contains several binding sites for hydrophobic compounds. The apparent specificity of various ''calmodulin antagonists'' for these sites was investigated. The Ki values for the inhibition of calmodulin-activated cyclic-nucleotide phoshodiesterase and myosin light-chain kinase was determined. In addition, the Kd values of the same compounds for binding to calmodulin were measured. The compounds could be separated into four groups. Group I and II compounds inhibited competitively the activation of the phosphodiesterase and myosin light-chain kinase by calmodulin. Group I compounds inhibited the activation of the phosphodiesterase and myosin light-chain kinase at identical concentrations. In contrast, group II compounds inhibited the activation of the phosphodiesterase at 5.sbd.10-fold lower concentrations than that of myosin light-chain kinase. Group III compounds inhibited the activation of these enzymes by an uncompetitive mechanism. Group IV compounds inhibited the activation of the phosphodiestease with Ki values above 10 .mu.M and did not affect the activation of myosin light-chain kinase. Binding of [3H]bepridil to calmodulin under equilibrium conditions yielded one high-affinity site (apparent Kd 0.4 .mu.M) and four low affinity sites (apparent Kd 44 .mu.M). Group I compounds interfered with the binding of bepridil to the high and low-affinity sites in a competitive manner. Group II compounds interfered in a noncompetitive manner with the high-affinity site and apparently competed only with one of the low-affinity sites. Group III compounds did not compete with any of the bepridil-binding sites. Nimodipine, a group III compound, bound to one site on calmodulin with a Kd value of 1.1 .mu.M. Other dihydropyridines competed with [3H]nimodipine for this site. The group I and II compounds, trifluoperazine and prenylamine, did not affect the binding of [3H]nimodipine. These data show that ''calmodulin antagonists'' can be differentiated into at least three distinct groups. Kinetic and binding data suggest that the three groups bind to at least three different sites on calmodulin. Selective occupation of these sites may inhibit specifically the activation of distinct enzymes.This publication has 41 references indexed in Scilit:
- Localization of felodipine (dihydropyridine) binding site on calmodulinBiochemistry, 1986
- Kinetics of calcium dissociation from calmodulin and its tryptic fragments. A stopped-flow fluorescence study using Quin 2 reveals a two-domain structureEuropean Journal of Biochemistry, 1985
- Cooperativity among calmodulin drug binding sitesBiochemistry, 1985
- Selective effects of CAPP1-calmodulin on its target proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Functional properties of covalent .beta.-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activationBiochemistry, 1985
- The nature of the trifluoperazine binding sites on calmodulin and troponin-CBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Calmodulin activates bovine-cardiac myosin light-chain kinase by increasing the affinity for myosin light-chain 2European Journal of Biochemistry, 1984
- Calcium‐dependent hydrophobic interaction chromatography of calmodulin, troponin C and their proteolytic fragmentsFEBS Letters, 1983
- Cadmium-113 nuclear magnetic resonance studies of proteolytic fragments of calmodulin: assignment of strong and weak cation binding sitesBiochemistry, 1983
- Stimulation of enzyme activities by fragments of calmodulinFEBS Letters, 1981